相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin
Oliver J. Stoetzer et al.
CANCER LETTERS (2013)
Primary Biliary Cirrhosis
Bhavik M. Bhandari et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2011)
Autoimmune hepatitis
Giorgina Mieli-Vergani et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division
Claudia von Montfort et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Circulating intercellular adhesion molecule-l (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes
A. W. THOMSON et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Apoptosis in Immune-Mediated Liver Diseases
Alisan Kahraman et al.
DIGESTIVE DISEASES (2010)
Apoptosis as a Mechanism for Liver Disease Progression
Maria Eugenia Guicciardi et al.
SEMINARS IN LIVER DISEASE (2010)
Medical Treatment of Primary Sclerosing Cholangitis: A Role for Novel Bile Acids and other (post-)Transcriptional Modulators?
Ulrich Beuers et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2009)
Clinical use of circulating nucleosomes
Stefan Holdenrieder et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers
Andreas E. Kremer et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats
Ping-Fang Hu et al.
JOURNAL OF HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
Cellular and molecular mechanisms of liver injury
Harmeet Malhi et al.
GASTROENTEROLOGY (2008)
A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
Zobair M. Younossi et al.
OBESITY SURGERY (2008)
Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease
Thomas Luft et al.
BLOOD (2007)
Interpreting serological tests in diagnosing autolmmune liver diseases
Pietro Invernizzi et al.
SEMINARS IN LIVER DISEASE (2007)
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C
N. Pelli et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Pathogenesis of autoimmune hepatitis:: from break of tolerance to immune-mediated hepatocyte apoptosis
Pascal Lapierre et al.
TRANSLATIONAL RESEARCH (2007)
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
Yusuf Yilmaz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Caspase-cleaved cytokeratin 18 and 20S proteasome in liver degeneration
Hubert Hetz et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2007)
Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation
E. Yagmur et al.
CLINICAL BIOCHEMISTRY (2007)
Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis
CK Fox et al.
LIVER (2001)
Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis
M Iwata et al.
LIVER (2000)
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology
C Tortorella et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2000)
分享论文
